BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 33238073)

  • 1. Histiocytic and dendritic cell neoplasms: Reappraisal of a Japanese series based on t(14;18) and neoplastic PD-L1 expression.
    Okada K; Takahara T; Suzuki Y; Kohno K; Sakakibara A; Satou A; Takahashi E; Nakamura S
    Pathol Int; 2021 Jan; 71(1):24-32. PubMed ID: 33238073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High frequency of clonal IG and T-cell receptor gene rearrangements in histiocytic and dendritic cell neoplasms.
    Huang W; Qiu T; Zeng L; Zheng B; Ying J; Feng X
    Oncotarget; 2016 Nov; 7(48):78355-78362. PubMed ID: 27823979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone.
    Feldman AL; Arber DA; Pittaluga S; Martinez A; Burke JS; Raffeld M; Camos M; Warnke R; Jaffe ES
    Blood; 2008 Jun; 111(12):5433-9. PubMed ID: 18272816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonally related histiocytic/dendritic cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a study of seven cases.
    Shao H; Xi L; Raffeld M; Feldman AL; Ketterling RP; Knudson R; Rodriguez-Canales J; Hanson J; Pittaluga S; Jaffe ES
    Mod Pathol; 2011 Nov; 24(11):1421-32. PubMed ID: 21666687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1.
    Gatalica Z; Bilalovic N; Palazzo JP; Bender RP; Swensen J; Millis SZ; Vranic S; Von Hoff D; Arceci RJ
    Oncotarget; 2015 Aug; 6(23):19819-25. PubMed ID: 26110571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High frequency of clonal immunoglobulin receptor gene rearrangements in sporadic histiocytic/dendritic cell sarcomas.
    Chen W; Lau SK; Fong D; Wang J; Wang E; Arber DA; Weiss LM; Huang Q
    Am J Surg Pathol; 2009 Jun; 33(6):863-73. PubMed ID: 19145200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follicular dendritic cell sarcoma: clinicopathologic study of 15 cases with emphasis on novel expression of MDM2, somatostatin receptor 2A, and PD-L1.
    Agaimy A; Michal M; Hadravsky L; Michal M
    Ann Diagn Pathol; 2016 Aug; 23():21-8. PubMed ID: 27402219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Descriptive Analysis of Histiocytic and Dendritic Cell Neoplasms: A Single-Institution Experience.
    Kim HM; Yang WI; Lyu CJ; Hahn SM; Yoon SO
    Yonsei Med J; 2020 Sep; 61(9):774-779. PubMed ID: 32882761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonally related follicular lymphomas and Langerhans cell neoplasms: expanding the spectrum of transdifferentiation.
    West DS; Dogan A; Quint PS; Tricker-Klar ML; Porcher JC; Ketterling RP; Law ME; McPhail ED; Viswanatha DS; Kurtin PJ; Dao LN; Ritzer RD; Nowakowski GS; Feldman AL
    Am J Surg Pathol; 2013 Jul; 37(7):978-86. PubMed ID: 23759932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The phosphatidylserine receptors, T cell immunoglobulin mucin proteins 3 and 4, are markers of histiocytic sarcoma and other histiocytic and dendritic cell neoplasms.
    Dorfman DM; Hornick JL; Shahsafaei A; Freeman GJ
    Hum Pathol; 2010 Oct; 41(10):1486-94. PubMed ID: 20656318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histiocytic and Dendritic Cell Sarcomas of Hematopoietic Origin Share Targetable Genomic Alterations Distinct from Follicular Dendritic Cell Sarcoma.
    Massoth LR; Hung YP; Ferry JA; Hasserjian RP; Nardi V; Nielsen GP; Sadigh S; Venkataraman V; Selig M; Friedmann AM; Samore W; Killian JK; Milante R; Giessinger J; Foley-Peres K; Marcus C; Severson E; Duncan D; Sivakumar S; Ross JS; Desphande V; Ramkissoon SH; Vergilio JA; Louissaint A; Zukerberg LR; Williams EA
    Oncologist; 2021 Jul; 26(7):e1263-e1272. PubMed ID: 33904632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinctive Histogenesis and Immunological Microenvironment Based on Transcriptional Profiles of Follicular Dendritic Cell Sarcomas.
    Laginestra MA; Tripodo C; Agostinelli C; Motta G; Hartmann S; Döring C; Rossi M; Melle F; Sapienza MR; Tabanelli V; Pileri A; Fuligni F; Gazzola A; Mannu C; Sagramoso CA; Lonardi S; Lorenzi L; Bacci F; Sabattini E; Borges A; Simonitsch-Klupp I; Cabecadas J; Campo E; Rosai J; Hansmann ML; Facchetti F; Pileri SA
    Mol Cancer Res; 2017 May; 15(5):541-552. PubMed ID: 28130401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Podoplanin (D2-40) is a novel marker for follicular dendritic cell tumors.
    Yu H; Gibson JA; Pinkus GS; Hornick JL
    Am J Clin Pathol; 2007 Nov; 128(5):776-82. PubMed ID: 17951199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fine needle aspiration cytology of histiocytic sarcoma with dendritic cell differentiation: a case of transdifferentiation from low-grade follicular lymphoma.
    Mehrotra S; Pan Z
    Diagn Cytopathol; 2015 Aug; 43(8):659-63. PubMed ID: 25993973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases.
    Pileri SA; Grogan TM; Harris NL; Banks P; Campo E; Chan JK; Favera RD; Delsol G; De Wolf-Peeters C; Falini B; Gascoyne RD; Gaulard P; Gatter KC; Isaacson PG; Jaffe ES; Kluin P; Knowles DM; Mason DY; Mori S; Müller-Hermelink HK; Piris MA; Ralfkiaer E; Stein H; Su IJ; Warnke RA; Weiss LM
    Histopathology; 2002 Jul; 41(1):1-29. PubMed ID: 12121233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential development of histiocytic sarcoma and diffuse large b-cell lymphoma in a patient with a remote history of follicular lymphoma with genotypic evidence of a clonal relationship: a divergent (bilineal) neoplastic transformation of an indolent B-cell lymphoma in a single individual.
    Wang E; Papalas J; Hutchinson CB; Kulbacki E; Huang Q; Sebastian S; Rehder C; Silbermins D; Moore J; Datto M
    Am J Surg Pathol; 2011 Mar; 35(3):457-63. PubMed ID: 21317718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KRAS mutation in secondary malignant histiocytosis arising from low grade follicular lymphoma.
    Choi SM; Andea AA; Wang M; Behdad A; Shao L; Zhang Y; Lu X; Dittmann D; Castro J; Chen YH; Gao J
    Diagn Pathol; 2018 Oct; 13(1):78. PubMed ID: 30322385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Programmed Cell Death 1 Ligands (PD-L1 and PD-L2) in Histiocytic and Dendritic Cell Disorders.
    Xu J; Sun HH; Fletcher CD; Hornick JL; Morgan EA; Freeman GJ; Hodi FS; Pinkus GS; Rodig SJ
    Am J Surg Pathol; 2016 Apr; 40(4):443-53. PubMed ID: 26752545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two cases of histiocytic sarcoma with BCL2 translocations and occult or subsequent follicular lymphoma.
    Fernandez-Pol S; Bangs CD; Cherry A; Arber DA; Gratzinger D
    Hum Pathol; 2016 Sep; 55():39-43. PubMed ID: 27134111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From the archives of MD Anderson Cancer Center: A case of concurrent follicular lymphoma and Langerhans cell sarcoma with a review of the literature.
    Tashakori M; Thakral B; Tang G; Khoury JD; Medeiros LJ
    Ann Diagn Pathol; 2021 Jun; 52():151720. PubMed ID: 33676171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.